Industries

Lead Generation for Pharmaceuticals & Biotech

Book a strategy call
All industries
Healthcare & Life Sciences

PBMs influence nearly 80% of U.S. prescriptions. Reach pharma & biotech buyers with compliant outreach. SalesHive books qualified meetings with SDR teams.

See how it works
US-basedDedicated SDR team
Phone + emailOne coordinated motion
Month to monthNo long-term contract
129K+
Qualified meetings booked
$2.5B+
Pipeline generated
2,285
Clients scaled
100%
US-based SDRs
Our Pharmaceuticals & Biotech track record

Yes, we have run Pharmaceuticals & Biotech outbound before.

These figures come straight from our CRM: every client account tagged with a Pharmaceuticals & Biotech industry that we booked meetings for. Client names stay private. Ask on your strategy call how those campaigns were targeted and what worked.

6Pharmaceuticals & Biotech client accounts
112Meetings booked for them
2019First year on record

Counted from client industry tags: biotechnology, pharmaceuticals. Minimum figures; refreshed hourly.

Industry brief

Built for how Pharmaceuticals & Biotech buyers actually buy

SalesHive is a B2B lead generation agency that books qualified meetings for pharmaceutical and biotech companies selling to scientific buyers across R and D, clinical, regulatory, manufacturing, and commercial teams.

SDR teams run compliant outbound across targeted lists, personalized email, and cold calling, positioning offers for Clinical Operations, Regulatory Affairs, and Market Access leaders who weigh validation and risk as heavily as features.

Outreach respects strict compliance boundaries and the long evaluation cycles where deal momentum stalls as priorities shift from discovery to clinical or launch to lifecycle management.

The Challenge

Why Pharmaceuticals & Biotech Sales Development is Hard

Between tight compliance requirements and complex access dynamics, where the three largest PBMs process nearly 80% of U.S. prescriptions, teams need precise targeting and disciplined messaging to earn meetings.

01

Compliance-first outreach expectations

Pharma and biotech buyers are trained to spot risk, especially around claims, inducements, and how data is handled. If your messaging feels promotional, unsubstantiated, or unclear on intended use, it can end the conversation before it starts.

02

Slow evaluation and onboarding

Even when there’s urgency, vendor onboarding often requires security reviews, quality oversight, and cross-functional approvals. Sales cycles stretch when prospects need validation plans, SOP alignment, and internal buy-in before a pilot can begin.

03

Many stakeholders, no clear owner

Purchasing decisions span R&D, clinical, QA, IT, procurement, and commercial teams, each with different success metrics. A single champion rarely controls the process, so progress depends on building consensus across the account.

04

Budget volatility and reprioritization

Biotech budgets can change quickly with financing cycles, trial results, partnership news, or internal portfolio decisions. A project that looked funded last month can be paused, re-scoped, or moved to a different team overnight.

05

Heavy documentation requirements

Life sciences buyers often expect proof, not promises, quality documentation, audit readiness, and clear contractual language. If you can’t quickly provide the right artifacts and answers, prospects may choose a “safer” incumbent.

06

Market access and pricing pressure

Commercial teams face ongoing pressure from payers, formulary controls, and pricing scrutiny, which raises the bar for ROI on any new initiative. Vendors must connect value directly to outcomes like launch readiness, speed-to-insight, or operational efficiency.

Our Approach

How We Generate Leads for Pharmaceuticals & Biotech

We combine compliant messaging, precise list building, and persistent multi-threaded outreach to book meetings with the right life sciences stakeholders at the right moment.

01

Compliant email outreach

We build messaging that respects industry guardrails while still creating urgency, grounded in use cases like clinical operations efficiency, quality readiness, manufacturing continuity, or commercial execution. Sequences are tailored by persona and lifecycle stage (discovery, clinical, tech transfer, launch, post-market).

Explore email outreach
02

Cold calling for access

When inboxes are crowded and gatekeeping is real, calling helps you break into target accounts and identify the true owners of initiatives. Our SDRs use structured call plays to multi-thread across functions and convert interest into scheduled meetings.

Explore cold calling
03

Lifecycle-based list building

We build and QA lists aligned to how pharma and biotech actually buy, by therapeutic area, modality, trial phase, manufacturing footprint, and commercial maturity. That means fewer wasted touches and more conversations with teams that have an active need right now.

Explore list building
04

Personalization at scale

SalesHive’s platform and AI-driven personalization help your outreach feel relevant without slowing down execution. We continuously optimize deliverability, messaging performance, and account coverage so you can forecast pipeline with confidence.

Tour the platform

Thirty minutes with a strategist who has run Pharmaceuticals & Biotech outbound before beats another month of guessing.

Book a strategy call
Who we reach

We Target Your Ideal Pharmaceuticals & Biotech Buyers

Our SDRs are trained to engage life sciences stakeholders with compliant, technical messaging tailored to therapeutic area, modality, and where the organization sits in the development-to-commercialization lifecycle.

Build my target list
Buyer coverageDecision-Makers We Reach
  • 01VP / Head of Clinical Operations
  • 02Director of Regulatory Affairs
  • 03VP, Technical Operations (Manufacturing / MSAT)
  • 04Head of Market Access & Payer Strategy
  • 05Director of Commercial Operations / Sales Operations

Questions, answered

Pharmaceuticals & Biotech outbound, explained

The short version is on the surface. Open any question to go deeper.

Why is lead generation harder for Pharmaceuticals & Biotech companies than most B2B industries?
Pharma and biotech buyers expect compliance-first, evidence-based messaging, and they quickly disengage from anything that sounds like an unsubstantiated claim or unclear “intended use.” Sales cycles are also slower because decisions span R&D, clinical, quality, IT, procurement, and commercial teams, often requiring security reviews, validation expectations, and documented processes before a pilot even starts. On top of that, priorities can shift fast with trial timelines, portfolio changes, or financing events, which can stall deals mid-stream.
Who should we target in pharma and biotech outbound to consistently book qualified meetings?
The right targets depend on where an organization sits in the development-to-commercialization lifecycle and what outcome you impact (trial execution, quality readiness, manufacturing continuity, launch performance, or market access). We commonly build account maps that include clinical operations, regulatory/quality, technical operations (MSAT/manufacturing), and commercial operations, then multi-thread outreach to find the real initiative owner. This reduces “dead-end” conversations and increases the odds of booking a meeting that can actually move forward.
How does SalesHive keep email outreach compliant and credible for pharma and biotech audiences?
We help you lead with precise, non-promotional positioning focused on operational outcomes and validated use cases, while avoiding language that can trigger compliance concerns (e.g., exaggerated performance claims or ambiguous data handling). Our team tailors sequences by persona and lifecycle stage, and we use our AI-powered platform with eMod personalization to make messages feel relevant without sacrificing consistency. We also continuously monitor deliverability and reply signals so you can scale outreach while protecting your domain reputation.
Does cold calling still work for pharma and biotech lead generation when gatekeeping is intense?
Yes, calling is often the fastest way to confirm who owns an initiative, understand what “stage” the account is in (clinical, tech transfer, launch, post-market), and route around inbox congestion. We use structured call plays designed for life sciences stakeholders, focusing on permission-based conversations and clear next steps rather than pushy pitching. Cold calling also enables multi-threading across functions to build consensus and convert interest into scheduled meetings.
What should we have ready to reduce friction after a pharma or biotech prospect says “this looks interesting”?
Expect detailed questions about security, data handling, quality processes, validation expectations, and contract language, often before a formal pilot is approved. We help by pre-qualifying accounts during outreach, capturing requirements early, and setting meetings with the right stakeholders so your team isn’t stuck repeating discovery with non-decision makers. If needed, we can also adjust targeting and messaging quickly on our month-to-month model as new objections and documentation requirements surface.
Healthcare & Life Sciences

Adjacent industries we also run

Healthcare IT Healthcare Services Medical Devices Telehealth All 47+ industries

Book a strategy call

Ready to fill your pipeline?

Choose a 30-minute time and we will map out exactly how SalesHive can book meetings for your team.

Category: Healthcare & Life Sciences